Targeting the androgen receptor in triple-negative breast cancer: current perspectives

por Mina, Alain, Yoder, Rachel, Sharma, Priyanka
Publicado en Onco Targets Ther (2017)

Racial/Ethnic differences in the prevalence of anxiety using the Vanderbilt ADHD scale in a diverse community outpatient setting

por Bauer, Nerissa S., Yoder, Rachel, Carroll, Aaron E., Downs, Stephen M.
Publicado en J Dev Behav Pediatr (2016)

Clinical and biomarker results from phase I/II study of PI3K inhibitor alpelisib plus nab-paclitaxel in HER2-negative metastatic breast cancer

por Sharma, Priyanka, Abramson, Vandana G., O’Dea, Anne, Nye, Lauren, Mayer, Ingrid, Pathak, Harsh B., Hoffmann, Marc, Stecklein, Shane R., Elia, Manana, Lewis, Sharon, Scott, Jecinta, De Jong, Jilliann A., Wang, Yen Y., Yoder, Rachel, Schwensen, Kelsey, Finke, Karissa, Heldstab, Jaimie, LaFaver, Stephanie, Williamson, Stephen K., Phadnis, Milind, Reed, Gregory A., Kimler, Bruce F., Khan, Qamar J., Godwin, Andrew K.
Publicado en Clin Cancer Res (2021)

Randomized phase II trial of anthracycline-free and anthracycline-containing neoadjuvant carboplatin chemotherapy regimens in stage I-III triple-negative breast cancer (NeoSTOP)

por Sharma, Priyanka, Kimler, Bruce F., O’Dea, Anne, Nye, Lauren, Wang, Yen Y., Yoder, Rachel, Staley, Joshua M., Prochaska, Lindsey, Wagner, Jamie, Amin, Amanda L., Larson, Kelsey, Balanoff, Christa, Elia, Manana, Crane, Gregory, Madhusudhana, Sheshadri, Hoffmann, Marc, Sheehan, Maureen, Rodriguez, Roberto, Finke, Karissa, Shah, Rajvi, Satelli, Deepti, Shrestha, Anuj, Beck, Larry, McKittrick, Richard, Pluenneke, Robert, Raja, Vinay, Beeki, Venkatadri, Corum, Larry, Heldstab, Jaimie, LaFaver, Stephanie, Prager, Micki, Phadnis, Milind, Mudaranthakam, Dinesh Pal, Jensen, Roy A., Godwin, Andrew K., Salgado, Roberto, Mehta, Kathan, Khan, Qamar
Publicado en Clin Cancer Res (2020)